[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 9, 1994

Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies

Author Affiliations

Boulder, Colo

 

vol 1, edited by Anna C. Mastroianni, Ruth Faden, and Daniel Federman (Committee on the Ethical and Legal Issues Relating to the Inclusion of Women in Clinical Studies, Institute of Medicine), 271 pp, $34.95, ISBN 0-309-04992-X, Washington, DC, National Academy Press, 1994.

JAMA. 1994;272(18):1467. doi:10.1001/jama.1994.03520180097047

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies, vol 2: Workshop and Commissioned Papers, edited by Anna C. Mastroianni, Ruth Faden, and Daniel Federman (Committee on the Ethical and Legal Issues Relating to the Inclusion of Women in Clinical Studies, Institute of Medicine), 247 pp, paper $29, ISBN 0-309-05040-5, Washington, DC, National Academy Press, 1994.

Twenty years ago, in the wake of the thalidomide and diethylstilbestrol (DES) disasters, it became unthinkable to include women of childbearing age in clinical research. Today, with the women's health movement protesting a lack of attention to women's medical problems, it has become unthinkable not to include them.

Responding to this dramatic reversal, the National Institute of Health's (NIH) Institute of Medicine in September 1992 convened a 16-member Committee on the Ethical and Legal Issues Relating to the Inclusion of Women in Clinical Studies. Women and Health Research, volume

First Page Preview View Large
First page PDF preview
First page PDF preview
×